Full Text View
Tabular View
No Study Results Posted
Related Studies
BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance) (BONINJPMS)
This study has been completed.
Study NCT01376102   Information provided by GlaxoSmithKline

First Received on June 16, 2011.   Last Updated on March 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoporosis
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Interventions listed in this trial
Ibandronate
Additional drug interventions recognized in this trial
Diphosphonates
Ibandronic acid
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services